Principles Guiding Nonpandemic Critical Care Research During a Pandemic

被引:11
作者
Cook, Deborah J. [1 ,2 ,3 ]
Kho, Michelle E. [4 ,5 ]
Duan, Eric H. [1 ,2 ,3 ,6 ]
Alhazzani, Waleed [1 ,2 ,3 ]
Takaoka, Alyson [2 ]
Clarke, France J. [2 ]
Zytaruk, Nicole [2 ]
Vanstone, Meredith [7 ]
机构
[1] McMaster Univ, Fac Hlth Sci, Dept Med, Div Crit Care, Hamilton, ON, Canada
[2] McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[3] St Josephs Healthcare Hamilton, Dept Crit Care, Hamilton, ON, Canada
[4] McMaster Univ, Fac Hlth Sci, Sch Rehabil Sci, Dept Physiotherapy, Hamilton, ON, Canada
[5] St Josephs Healthcare Hamilton, Physiotherapy Dept, Hamilton, ON, Canada
[6] Niagara Hlth, Div Crit Care, St Catharines, ON, Canada
[7] McMaster Univ, Fac Hlth Sci, Dept Family Med, Hamilton, ON, Canada
关键词
clinical research; critical care research; healthcare worker; pandemic; priority; PUBLIC-HEALTH EMERGENCY; CLINICAL-RESEARCH; RESEARCH ETHICS;
D O I
10.1097/CCM.0000000000004538
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To describe the importance of critical care clinical research that is not pandemic-focused during pandemic times; outline principles to assist in the prioritization of nonpandemic research during pandemic times; and propose a guiding framework for decisions about whether, when and how to continue nonpandemic research while still honoring the moral and scientific imperative to launch research that is pandemic-focused. Design/Data Sources: Using in-person, email, and videoconference exchanges, we convened an interprofessional clinical research group, conducted a literature review of empirical studies, ethics documents and expert commentaries (2010 to present), and viewed traditional and social media posts (March 2020 to May 2020). Stakeholder consultation involved scientific, ethics, clinical, and administrative leaders. Setting: Clinical research in the ICU. Patients: Patients with and without coronavirus disease 2019. Interventions: None. Measurements and Main Results: While clinical research should be prioritized to advantage patients with coronavirus disease 2019 in order to care for affected patients, it ideally would not unduly disadvantage patients without coronavirus disease 2019. Thus, timely, rigorous, relevant, and ethical clinical research is needed to improve the care and optimize outcomes for both patients with and without coronavirus disease 2019, acknowledging how many studies that are not exclusively focused on coronavirus disease 2019 remain relevant to patients with coronavirus disease 2019. Considerations to continue nonpandemic-focused research include the status of the pandemic, local jurisdictional guidance, capacity and safety of bedside and research personnel, disposition of patients already enrolled in nonpandemic studies, analyzing characteristics of each nonpandemic-focused study, research oversight, and final reporting requirements. Conclusions: Deliberation about continuing nonpandemic research should use objective, transparent criteria considering several aspects of the research process such as bedside and research staff safety, infection control, the informed consent model, protocol complexity, data collection, and implementation integrity. Decisions to pause or pursue nonpandemic research should be proportionate, transparent, and revisited as the pandemic abates.
引用
收藏
页码:1403 / 1410
页数:8
相关论文
共 37 条
[1]  
[Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932
[2]  
[Anonymous], 2020, GUIDANCE CONDUCT CLI, P16
[3]   Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State [J].
Arentz, Matt ;
Yim, Eric ;
Klaff, Lindy ;
Lokhandwala, Sharukh ;
Riedo, Francis X. ;
Chong, Maria ;
Lee, Melissa .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1612-1614
[4]   Participation of ICUs in Critical Care Pandemic Research: A Province Wide, Cross-Sectional Survey [J].
Burns, Karen E. A. ;
Rizvi, Leena ;
Tan, Wylie ;
Marshall, John C. ;
Pope, Karen .
CRITICAL CARE MEDICINE, 2013, 41 (04) :1009-1016
[5]  
[Busta ER. 57. National Academies of Science E and Medicine
[6]  
Health and Medical Division
[7]  
Board on Health Sciences Policy Board on Global Health
[8]  
Committee on Clinical Trials during the 2014-2015 Ebola Outbreak 57. National Academies of Science E and Medicine
[9]  
Health and Medical Division
[10]  
Board on Health Sciences Policy Board on Global Health